Paul J. Clancy
2012
In 2012, Paul J. Clancy earned a total compensation of $3.7M as EVP, Chief Financial Officer at Biogen, a 25% increase compared to previous year.
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $18,702 |
---|---|
Non-Equity Incentive Plan | $607,941 |
Salary | $635,820 |
Stock Awards | $2,287,448 |
Other | $141,584 |
Total | $3,691,495 |
Clancy received $2.3M in stock awards, accounting for 62% of the total pay in 2012.
Clancy also received $18.7K of change in pension value and nonqualified deferred compensation earnings, $607.9K in non-equity incentive plan, $635.8K in salary and $141.6K in other compensation.
Rankings
In 2012, Paul J. Clancy's compensation ranked 1,829th out of 11,487 executives tracked by ExecPay. In other words, Clancy earned more than 84.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,829 | 84th |
Manufacturing | 657 | 85th |
Chemicals And Allied Products | 149 | 88th |
Drugs | 83 | 91st |
Biological Products, Except Diagnostic Substances | 13 | 92nd |
Clancy's colleagues
We found four more compensation records of executives who worked with Paul J. Clancy at Biogen in 2012.